These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12127545)

  • 1. Binding modes of two novel dinucleotide inhibitors of HIV-1 integrase.
    Guenther S; Nair V
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2233-6. PubMed ID: 12127545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking dinucleotides to HIV-1 integrase carboxyl-terminal domain to find possible DNA binding sites.
    Zhu HM; Chen WZ; Wang CX
    Bioorg Med Chem Lett; 2005 Jan; 15(2):475-7. PubMed ID: 15603976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.
    Molteni V; Greenwald J; Rhodes D; Hwang Y; Kwiatkowski W; Bushman FD; Siegel JS; Choe S
    Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):536-44. PubMed ID: 11264582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
    Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
    FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integrase.
    Taktakishvili M; Neamati N; Pommier Y; Nair V
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1433-5. PubMed ID: 11378371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
    Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM
    J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of HIV-1 integrase.
    Chiu TK; Davies DR
    Curr Top Med Chem; 2004; 4(9):965-77. PubMed ID: 15134551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and inhibition of HIV integrase by a novel dinucleotide.
    Taktakishvili M; Neamati N; Pommier Y; Nair V
    Bioorg Med Chem Lett; 2000 Feb; 10(3):249-51. PubMed ID: 10698446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting HIV-1 integrase with strand transfer inhibitors.
    Li Y; Xuan S; Feng Y; Yan A
    Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of novel allosteric peptide inhibitors of HIV integrase identify new interactions at the LEDGF binding site.
    Rhodes DI; Peat TS; Vandegraaff N; Jeevarajah D; Newman J; Martyn J; Coates JA; Ede NJ; Rea P; Deadman JJ
    Chembiochem; 2011 Oct; 12(15):2311-5. PubMed ID: 21850718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors.
    Gupta P; Garg P; Roy N
    Mol Divers; 2011 Aug; 15(3):733-50. PubMed ID: 21327540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the fundamental interactions between LEDGF binding site inhibitors and integrase combining docking and molecular dynamics simulations.
    De Luca L; Morreale F; Chimirri A
    J Chem Inf Model; 2012 Dec; 52(12):3245-54. PubMed ID: 23194297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of biological activity with active site binding modes of geminal disulfone HIV-1 integrase inhibitors.
    Meadows DC; Tantillo DJ; Gervay-Hague J
    ChemMedChem; 2006 Sep; 1(9):959-64. PubMed ID: 16952140
    [No Abstract]   [Full Text] [Related]  

  • 14. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.
    Barreca ML; Ortuso F; Iraci N; De Luca L; Alcaro S; Chimirri A
    Biochem Biophys Res Commun; 2007 Nov; 363(3):554-60. PubMed ID: 17889829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully flexible low-mode docking: application to induced fit in HIV integrase.
    Keserû GM; Kolossváry I
    J Am Chem Soc; 2001 Dec; 123(50):12708-9. PubMed ID: 11741448
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
    Quashie PK; Han YS; Hassounah S; Mesplède T; Wainberg MA
    PLoS One; 2015; 10(6):e0128310. PubMed ID: 26046987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
    Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
    Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of novel diketoacid-containing ferrocene inhibitors of HIV-1 integrase.
    da Silva CH; Del Ponte G; Neto AF; Taft CA
    Bioorg Chem; 2005 Aug; 33(4):274-84. PubMed ID: 16023487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of specific inhibitors of the 3'-processing step of HIV-1 integrase.
    Chi G; Seo BI; Nair V
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):481-4. PubMed ID: 16247975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on developing small molecule inhibitors targeting HIV-1 integrase.
    Tan JJ; Liu C; Sun XH; Cong XJ; Hu LM; Wang CX; Liang XJ
    Mini Rev Med Chem; 2012 Aug; 12(9):875-89. PubMed ID: 22512579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.